We have reported that GSK-3β inhibition, using a specific inhibitor or using materials with GSK-3β inhibitory effects, reduced motor neuronal cell death in motor neurons transfected with the G93A or A4V mutant hSOD1 genes in an in vitro model of ALS [15, 39]. Here, GSK3B is linked to amyotrophic lateral sclerosis.